Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:10847306rdf:typepubmed:Citationlld:pubmed
pubmed-article:10847306lifeskim:mentionsumls-concept:C0036341lld:lifeskim
pubmed-article:10847306lifeskim:mentionsumls-concept:C0005586lld:lifeskim
pubmed-article:10847306lifeskim:mentionsumls-concept:C0009079lld:lifeskim
pubmed-article:10847306lifeskim:mentionsumls-concept:C0036337lld:lifeskim
pubmed-article:10847306lifeskim:mentionsumls-concept:C0459435lld:lifeskim
pubmed-article:10847306lifeskim:mentionsumls-concept:C2603343lld:lifeskim
pubmed-article:10847306pubmed:issue5lld:pubmed
pubmed-article:10847306pubmed:dateCreated2000-6-21lld:pubmed
pubmed-article:10847306pubmed:abstractTextThe aim of this study was to evaluate the 24-month response to clozapine in patients with schizophrenia, schizoaffective disorder, or psychotic bipolar disorder.lld:pubmed
pubmed-article:10847306pubmed:languageenglld:pubmed
pubmed-article:10847306pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10847306pubmed:citationSubsetIMlld:pubmed
pubmed-article:10847306pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10847306pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10847306pubmed:statusMEDLINElld:pubmed
pubmed-article:10847306pubmed:monthMaylld:pubmed
pubmed-article:10847306pubmed:issn0160-6689lld:pubmed
pubmed-article:10847306pubmed:authorpubmed-author:CassanoG BGBlld:pubmed
pubmed-article:10847306pubmed:authorpubmed-author:PineWWlld:pubmed
pubmed-article:10847306pubmed:authorpubmed-author:Dell'OssoLLlld:pubmed
pubmed-article:10847306pubmed:authorpubmed-author:CiapparelliAAlld:pubmed
pubmed-article:10847306pubmed:authorpubmed-author:ChiavacciM...lld:pubmed
pubmed-article:10847306pubmed:authorpubmed-author:FenziMMlld:pubmed
pubmed-article:10847306pubmed:issnTypePrintlld:pubmed
pubmed-article:10847306pubmed:volume61lld:pubmed
pubmed-article:10847306pubmed:ownerNLMlld:pubmed
pubmed-article:10847306pubmed:authorsCompleteYlld:pubmed
pubmed-article:10847306pubmed:pagination329-34lld:pubmed
pubmed-article:10847306pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:10847306pubmed:meshHeadingpubmed-meshheading:10847306...lld:pubmed
pubmed-article:10847306pubmed:meshHeadingpubmed-meshheading:10847306...lld:pubmed
pubmed-article:10847306pubmed:meshHeadingpubmed-meshheading:10847306...lld:pubmed
pubmed-article:10847306pubmed:meshHeadingpubmed-meshheading:10847306...lld:pubmed
pubmed-article:10847306pubmed:meshHeadingpubmed-meshheading:10847306...lld:pubmed
pubmed-article:10847306pubmed:meshHeadingpubmed-meshheading:10847306...lld:pubmed
pubmed-article:10847306pubmed:meshHeadingpubmed-meshheading:10847306...lld:pubmed
pubmed-article:10847306pubmed:meshHeadingpubmed-meshheading:10847306...lld:pubmed
pubmed-article:10847306pubmed:meshHeadingpubmed-meshheading:10847306...lld:pubmed
pubmed-article:10847306pubmed:meshHeadingpubmed-meshheading:10847306...lld:pubmed
pubmed-article:10847306pubmed:meshHeadingpubmed-meshheading:10847306...lld:pubmed
pubmed-article:10847306pubmed:meshHeadingpubmed-meshheading:10847306...lld:pubmed
pubmed-article:10847306pubmed:meshHeadingpubmed-meshheading:10847306...lld:pubmed
pubmed-article:10847306pubmed:meshHeadingpubmed-meshheading:10847306...lld:pubmed
pubmed-article:10847306pubmed:year2000lld:pubmed
pubmed-article:10847306pubmed:articleTitleClozapine for treatment-refractory schizophrenia, schizoaffective disorder, and psychotic bipolar disorder: a 24-month naturalistic study.lld:pubmed
pubmed-article:10847306pubmed:affiliationDepartment of Psychiatry, Neurobiology, Pharmacology and Biotechnology, University of Pisa, Italy.lld:pubmed
pubmed-article:10847306pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:10847306pubmed:publicationTypeClinical Triallld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10847306lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10847306lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10847306lld:pubmed